Abstract
Background Portion sizes of many foods have increased over time and reducing food portion sizes has been proposed as a public health strategy to reduce obesity. However, the extent to which reducing food portion sizes affects daily energy intake and body weight is unclear.
Objective To systematically review and meta-analyse experimental studies that have examined the effect that serving smaller vs. larger portion sizes has on total daily energy intake.
Design We used systematic review methodology to search identify eligible articles that used an experimental design to manipulate portion size served to human participants and measured energy intake for a minimum of one day. Multi-level meta-analysis was used to used to pool effects of portion size on daily energy intake.
Results Fourteen eligible studies were included and 85 effects were included in the primary meta-analysis. There was a moderate-to-large reduction in daily energy intake when comparing smaller vs. larger portions (SMD = -.709 [95% CI: -.956 to -.461], p < .001, I2 = 80.6%) and evidence of a dose dependent response. Larger reductions to portion size and reducing portion sizes of multiple meals per day both resulted in larger decreases in daily energy intake. There was also evidence of a curvilinear relationship between portion size and daily energy intake, whereby reductions to daily energy intake were markedly smaller when reducing portion size from very large portions. In a subset of studies that measured body weight (n=5), being served smaller portions was associated with less weight gain than larger portions (SMD = .536 ([95% CI: .268 to .803], p < .001, I2 = 47.0%).
Conclusions Smaller food portion sizes substantially decrease daily energy intake and there is evidence that over time this results in lower body weight. Reducing food portion sizes may be an effective population level strategy to reduce obesity.
Competing Interest Statement
All authors report no conflicts of interest. ER has previously received funding from the American Beverage Association and Unilever for projects unrelated to the present research.
Clinical Trial
Registered on PROSPERO (CRD42020223973)
Funding Statement
No external funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A - systematic review
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Registration. Registered on PROSPERO (CRD42020223973).
Data Sharing. Data described in the manuscript, code book, and analytic code is publicly and freely available without restriction at https://osf.io/dj4yf/
Data Availability
Data described in the manuscript, code book, and analytic code is publicly and freely available without restriction at https://osf.io/dj4yf/
